Leadingpharm-Deep Blue Ocean (Zhengzhou) MAH Platform and Liquid Formulation Engineering Research Center Approved for Zhengzhou Engineering Research Center

Recently, after strict evaluation by experts from Zhengzhou Development and Reform Commission, Leadingpharm-Deep Blue Ocean (Zhengzhou) MAH Platform and Liquid Formulation Engineering Research Center have been approved as Zhengzhou Engineering Research Center.
 

As one of the city-level research and development platforms, Zhengzhou Engineering Research Center is an important component of the technological innovation system. It is a research and development institution established based on enterprises, universities, and research institutions with technological and comprehensive advantages. The aim is to cultivate and improve sustainable innovation capabilities, build a bridge between industry and scientific research, accelerate the transformation of scientific research achievements into real productivity, promote industrial technological progress and core competitiveness by establishing facilities for engineering research and verification, and mechanisms conducive to technological innovation and achievement transformation.

As a pharmaceutical research and development enterprise, Deep Blue Ocean will continuously strengthen platform construction, accelerate the transformation of scientific and technological achievements into productivity, and help improve the overall technological level of the pharmaceutical industry in Henan Province. This is of great significance for improving the independent innovation ability and core competitiveness of Henan Province's industry, implementing an innovation driven development strategy, and promoting mass entrepreneurship and innovation work.
 

The Deep Blue Ocean MAH platform and Liquid Formulation Engineering Research Center focus on the research and production transformation of liquid formulations (injection water injections, freeze-dried powder injections, sterile powder injections, oral liquids, inhalation formulations, eye drops, etc.) for generic and innovative drugs. It provides services for domestic and foreign pharmaceutical industry enterprises in various aspects such as consistency evaluation research and development, registration, and production transformation of generic and innovative drug liquid formulations, ensuring that the research and development of liquid formulation consistency evaluation can be carried out efficiently, and meeting the demand for this product in domestic and foreign markets.